Mfg Part Number
Ab01187-2.0
Vector Labs Ab01187-2.0 Anti-FceR1 alpha [Mar-1], Mouse IgG2a, lambda (200 μg)
Quick Overview
Vector Labs Ab01187-2.0 Anti-FceR1 alpha [Mar-1], Mouse IgG2a, lambda (200 μg)
$517.40
Order will ship within 1-3 business days
| Product Class: | Purified |
|---|---|
| Clone ID: | Mar-1 |
| Synonyms: | Fcer1a; Fc epsilon RI alpha; FceRIa; FceRI alpha; FceRI-α; high affinity IgE receptor; High affinity immunoglobulin epsilon receptor subunit alpha;Fce1a; Fc-epsilon RI-alpha; FcERI; IgE Fc receptor subunit alpha |
| Amount: | 200 μg |
| Application Codes Clone: | IP; FC; IHC; deplete |
| Shipping Temperature: | Wet Ice |
| Buffer Composition: | PBS with 0.02% Proclin 300. |
| Original Format: | IgG |
| Storage Temperature: | Store at 4⁰C for up to 3 months. For longer storage, aliquot and store at -20⁰C. |
| Chimeric Use Statement: | This chimeric mouse antibody was made using the variable domain sequences of the original Armenian Hamster IgG format, for improved compatibility with existing reagents, assays and techniques. |
| Specificity Statement: | This antibody specifically targets the non-signalling alpha chain of the FceR1 complex. |
| Application Notes: | This antibody has been used in flow cytometric analysis of FceR1 alpha cell surface expression by basophils (Min et al, 2004; Chen et al, 2009), and immunohistochemical analysis of epidermal sheets (Holzmann et al, 2004). It has also been used in immunoprecipitation analysis of cell lysates from lung cDCs and MC/9 mast cells (Grayson et al, 2007). In vitro incubation of basophils with this antibody blocks subsequent MAR-1 staining, but does not activate basophil IL-4 production (Sokol et al, 2008). Intravenous treatment of mice with this antibody results in basophil depletion in peripheral blood, spleen, bone marrow and liver, but not skin or intraperitoneal mast cell depletion (Sokol et al, 2008). Following treatment with this antibody, basophil-depleted mice display impaired Th2 differentiation upon papain immunisation (Sokol et al, 2008). However, MAR-1 treated mice respond normally to high-dose intravenous Ig in both the K/BxN serum transfer arthritis and collagen-induced arthritis models, despite basophil depletion (Campbell et al, 2014). |
| Brand | Vector Labs |
|---|---|
| UNSPSC | 12161500 |